NETSPOT: New Drug Trials Snapshot Posted

A new DRUG TRIALS SNAPSHOT FOR NETSPOT is now available.

NETSPOT is a drug for detection of a specific type of tumors called somatostatin receptor positive neuro-endocrine tumors (NETs).

NETs are rare tumors that develop in certain hormone-producing cells of the body’s neuro-endocrine system.

Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.